Forte Biosciences Operating Income

Forte Biosciences (FBRX) currently reports a operating income of $-90M as of June 2026. That compares with $-44M in the prior-year period — down 106.0% year over year. Use the charts on this page to explore Forte Biosciences's operating income history and peer comparisons.

Forte Biosciences's operating income decreased from $-44M to $-90M — a 106.0% year-over-year decrease (period ending June 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Forte Biosciences reported $-90M in operating income as of June 2026. That compares with $-44M in the prior-year period — down 106.0% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current operating income of $-90M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Forte Biosciences, and consider following FBRX for alerts when major investors trade the stock.

Forte Biosciences is classified in the Healthcare sector. On operating income, it currently shows $-90M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing FBRX with unrelated industries.